Pantoprazole Tillomed Laboratories (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Erosive esophagitis: accelerates mucosal healing in patients with endoscopically confirmed erosion.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the parietal cell surface, inhibiting the final step of gastric acid secretion. By blocking this pump, it markedly lowers both basal and stimulated gastric acidity, allowing damaged mucosa to heal and reducing acid‑related symptoms.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea or abdominal discomfort.
• Flatulence: excess gas formation.
• Constipation: occasional bowel habit change.
• Dry mouth: reduced salivary flow.

Serious or Rare Side Effects

• Severe allergic reactions: rash, itching, swelling, or anaphylaxis.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, tremor, or cardiac arrhythmia.
• Bone fractures: increased risk with long‑term use.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.
• Liver enzyme elevation: signs of hepatic injury.

When prescribing Pantoprazole, clinicians should consider several safety aspects:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Monitor long‑term users: watch for bone density loss and magnesium deficiency.
• Pregnancy and lactation: use only if the potential benefit outweighs risk.
• Elderly patients: start at the lowest effective dose and monitor for falls.
• Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption due to higher gastric pH.
• HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect, potentially increasing cardiovascular risk.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation parameters.
• Methotrexate (high dose): reduced renal clearance; check serum levels.
• Digoxin: slight rise in serum concentration; observe for toxicity signs.